PHENO LOCK
LIVE

Serial Number

97626317

Owner

Quell Therapeutics Limited

Attorney

Carlynn Ferguson

Filing Date

Oct 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PHENO LOCK Trademark

Serial Number: 97626317 • Registration: 7201861

PHENO LOCK is a trademark filed by Quell Therapeutics Limited on October 10, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently registered and active.

Owner Contact Info

Quell Therapeutics Limited (4 trademarks)

3rd Floor, Translation & Innovation Hub
London W120BZ , GB

Entity Type: 99

Trademark Details

Filing Date

October 10, 2022

Registration Date

October 24, 2023

Published for Opposition

August 8, 2023

Goods & Services

Pharmaceutical manufacturing and processing; biological, biotechnological and biopharmaceutical manufacturing and manufacturing processing; manufacturing processing of biological tissue, blood, cell and genetic material; viral vector production, namely manufacture; gene therapy production, namely manufacture; custom manufacture of pharmaceutical and biological formulations and products; processing and modification of human and animal cells in the custom manufacture of pharmaceutical and biological formulations and products

Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use, namely, for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; pharmaceutical, medical and veterinary preparations for diagnostic, therapeutic and prophylactic purposes, namely, for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; pharmaceutical preparations for cell therapy; pharmaceutical preparations for gene therapy; pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; human and animal cells and parts, namely, stem cells thereof for medical and veterinary purposes; T cells for medical and veterinary purposes; regulatory T cells for medical and veterinary purposes; preparations of blood or cells extracted from humans and animals which have been adapted for therapeutic purposes; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; immunological agents and preparations for medical purposes; pharmaceutical preparations for therapies to modulate the immune system; pharmaceutical preparations for therapies for autoimmune conditions and immunological disorders; chimeric antigen receptors and therapeutic preparations for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; [ Colostral antibodies for diagnostic, medical, therapeutic and prophylactic use, namely, for medical conditions caused by the immune system; ] pharmaceutical preparations for therapeutic delivery of nucleic acids; viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; medical pharmaceutical preparations containing viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection

Class 1: Chemical and biological preparations for use in science and industry; chemical and biological preparations for non-medical purposes; Chemical and biological preparations for genetically modifying human and animal cells for non-medical purposes; reagents for use in the genetic modification of human and animal cells for scientific or medical research use; human and animal cells and parts in the nature of stem cells thereof for scientific and research purposes; T cells for scientific and research purposes; regulatory T cells for scientific and research purposes; preparations of blood or cells extracted from humans and animals for scientific and research purposes; immunological agents and preparations for non-medical purposes; chimeric antigen receptors and preparations thereof for scientific and research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids; synthetic deoxyribonucleic acids for scientific purposes; viral vectors for use in science and industry; nucleic acid vectors for use in science and industry

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 5, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2025 REAP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Feb 13, 2024 NURC
AMENDMENT UNDER SECTION 7 - PROCESSED
Jan 5, 2024 A7OK
TEAS SECTION 7 REQUEST RECEIVED
Jan 4, 2024 ES7R
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 18, 2023 APRE
TEAS SECTION 7 REQUEST RECEIVED
Oct 31, 2023 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 24, 2023 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Sep 20, 2023 CHPB
ASSIGNED TO PETITION STAFF
Sep 20, 2023 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 29, 2023 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jun 30, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 23, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 27, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2022 NWOS
NEW APPLICATION ENTERED
Oct 13, 2022 NWAP